WO2003026565A3 - Composition and treatment method for brain and spinal cord injuries - Google Patents
Composition and treatment method for brain and spinal cord injuries Download PDFInfo
- Publication number
- WO2003026565A3 WO2003026565A3 PCT/US2002/028918 US0228918W WO03026565A3 WO 2003026565 A3 WO2003026565 A3 WO 2003026565A3 US 0228918 W US0228918 W US 0228918W WO 03026565 A3 WO03026565 A3 WO 03026565A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tissue
- composition
- central nervous
- nervous system
- brain
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 210000004556 brain Anatomy 0.000 title 1
- 208000029028 brain injury Diseases 0.000 title 1
- 208000020431 spinal cord injury Diseases 0.000 title 1
- 210000001519 tissue Anatomy 0.000 abstract 5
- 210000003169 central nervous system Anatomy 0.000 abstract 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 206010048962 Brain oedema Diseases 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000003190 augmentative effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 230000036770 blood supply Effects 0.000 abstract 1
- 208000006752 brain edema Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000003405 preventing effect Effects 0.000 abstract 1
- 210000002330 subarachnoid space Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002335736A AU2002335736A1 (en) | 2001-09-24 | 2002-09-11 | Composition and treatment method for brain and spinal cord injuries |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/962,009 | 2001-09-24 | ||
US09/962,009 US6683066B2 (en) | 2001-09-24 | 2001-09-24 | Composition and treatment method for brain and spinal cord injuries |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003026565A2 WO2003026565A2 (en) | 2003-04-03 |
WO2003026565A3 true WO2003026565A3 (en) | 2003-11-20 |
Family
ID=25505317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/028918 WO2003026565A2 (en) | 2001-09-24 | 2002-09-11 | Composition and treatment method for brain and spinal cord injuries |
Country Status (3)
Country | Link |
---|---|
US (4) | US6683066B2 (en) |
AU (1) | AU2002335736A1 (en) |
WO (1) | WO2003026565A2 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040045560A1 (en) * | 2002-05-23 | 2004-03-11 | New England Medical Center Hospitals, Inc. | Computer-assisted multi-dimensional patient-selection |
WO2003101281A2 (en) * | 2002-06-03 | 2003-12-11 | Uab Research Foundation | Method for reducing obstructive hydrocephalus |
US7923032B2 (en) * | 2002-11-26 | 2011-04-12 | Seacoast Neuroscience, Inc. | Buoyant polymer particles for delivery of therapeutic agents to the central nervous system |
US20060034946A1 (en) * | 2004-08-13 | 2006-02-16 | Yanming Wang | Irrigating solution for neurosurgical procedures |
US20060057065A1 (en) * | 2004-09-11 | 2006-03-16 | Yanming Wang | Composition and method to prevent and treat brain and spinal cord injuries |
FR2886153B1 (en) * | 2005-05-27 | 2009-04-10 | Gemac Sa | COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS |
NZ566067A (en) * | 2005-07-21 | 2009-11-27 | Cleveland Clinic Foundation | Medical oscillating compliance devices and uses thereof |
US7473684B2 (en) * | 2005-09-16 | 2009-01-06 | Selamine Limited | Bisphosphonate formulation |
US7759309B2 (en) * | 2006-05-19 | 2010-07-20 | Yanming Wang | Use of polypeptides in treating tissue injury |
US20100239562A1 (en) * | 2006-05-22 | 2010-09-23 | The Johns Hopkins University | Kv CHANNELS IN NEURODEGENERATION AND NEUROPROTECTION |
US20080045611A1 (en) * | 2006-08-17 | 2008-02-21 | Milan Radojicic | Methods for the therapeutic use of a carbonic anhydrase inhibitor for reducing spinal cord edema |
US10632237B2 (en) | 2006-10-09 | 2020-04-28 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
ES2845146T3 (en) | 2006-10-09 | 2021-07-26 | Neurofluidics Inc | Cerebrospinal fluid purification system |
US10850235B2 (en) | 2006-10-09 | 2020-12-01 | Minnetronix, Inc. | Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
US9386939B1 (en) | 2007-05-10 | 2016-07-12 | Fonar Corporation | Magnetic resonance imaging of the spine to detect scoliosis |
WO2009058353A1 (en) * | 2007-11-02 | 2009-05-07 | The Cleveland Clinic Foundation | Device for increasing cerebral blood flow |
US20090123373A1 (en) * | 2007-11-05 | 2009-05-14 | Yanming Wang | Amyloid-imaging agents |
WO2011111070A2 (en) * | 2010-03-09 | 2011-09-15 | Bdr Pharmaceuticals International Pvt. Ltd. | Novel injectable combination |
EP2392342A1 (en) * | 2010-06-04 | 2011-12-07 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Compositions for use in the treatment or diagnosis of prion diseases |
US9649047B1 (en) * | 2011-04-22 | 2017-05-16 | Fonar Corporation | Monitoring and treatment of multiple sclerosis |
US9766310B1 (en) | 2013-03-13 | 2017-09-19 | Fonar Corporation | Method and apparatus for magnetic resonance imaging of the cranio-cervical junction |
WO2016077457A1 (en) | 2014-11-11 | 2016-05-19 | Clara Foods Co. | Methods and compositions for egg white protein production |
US11147540B2 (en) | 2015-07-01 | 2021-10-19 | Minnetronix, Inc. | Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue |
CN108778355B (en) | 2015-12-04 | 2021-04-30 | 米奈特朗尼克斯有限公司 | Systems and methods for regulating cerebrospinal fluid |
RU2636616C1 (en) * | 2017-01-17 | 2017-11-24 | Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" | Combined drug for primary neuroprotection |
CN106727769A (en) * | 2017-03-01 | 2017-05-31 | 周博成 | The application of one ball plane tree bark extract and preparation method and field of medicaments |
WO2020041905A1 (en) * | 2018-08-31 | 2020-03-05 | The University Of British Columbia | Methods for identifying compounds suitable for treatment of central nervous system trauma and uses of those compounds |
KR20220034848A (en) | 2019-07-11 | 2022-03-18 | 클라라 푸드즈 컴퍼니 | Protein composition and edible products thereof |
US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
CN114099721B (en) * | 2021-11-30 | 2023-07-14 | 华兰生物工程重庆有限公司 | Globulin pasteurization process using combined protectant |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4780456A (en) * | 1984-10-10 | 1988-10-25 | Crinos Industria Farmacobiologica S.P.A. | Pharmaceutical or dietetic composition having a high antiarteriosclerotic activity |
US4830849A (en) * | 1980-04-14 | 1989-05-16 | Thomas Jefferson University | Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
JPH02102290A (en) * | 1988-10-07 | 1990-04-13 | Nippon Oil & Fats Co Ltd | Solubilized tocopherol |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54117034A (en) | 1978-02-28 | 1979-09-11 | Nippon Shoji Kk | Treating agent for consciousness and perception motion disorder |
US4758431A (en) | 1980-04-14 | 1988-07-19 | Thomas Jefferson University | Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US5085630A (en) | 1980-04-14 | 1992-02-04 | Thomas Jefferson University | Oxygenated fluorocarbon nutrient solution |
US4445500A (en) | 1982-03-03 | 1984-05-01 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4393863A (en) | 1980-04-14 | 1983-07-19 | Thomas Jefferson University | Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4465850A (en) | 1980-09-02 | 1984-08-14 | Merck & Co., Inc. | Treatment of brain injury due to gray matter edema with (indanyloxy) butanoic acids |
US4445887A (en) | 1982-03-03 | 1984-05-01 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4906644A (en) | 1986-11-20 | 1990-03-06 | Mitsubishi Kasei Corporation | Lipid-peroxide formation inhibiting composition and novel compounds useful therefor |
WO1989006129A1 (en) | 1987-12-29 | 1989-07-13 | Dainippon Pharmaceutical Co., Ltd. | Agent for treating ischemic brain trouble |
US5395314A (en) | 1990-10-10 | 1995-03-07 | Life Resuscitation Technologies, Inc. | Brain resuscitation and organ preservation device and method for performing the same |
US5486530A (en) | 1991-04-27 | 1996-01-23 | Boehringer Mannheim Gmbh | Use of torasemide for the treatment of brain oedemas |
US5308832A (en) | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
US5879677A (en) | 1992-12-09 | 1999-03-09 | The Scripps Research Institute | Method for inhibition of cerebral tissue factor mediated reperfusion damage |
US5755237A (en) | 1995-06-07 | 1998-05-26 | Rodriguez; Victorio C. | Therapeutic use of acetazolamide for the treatment of brain edema |
WO1999002139A1 (en) | 1997-07-10 | 1999-01-21 | Keith Baker | Methods for universally distributing therapeutic agents to the brain |
-
2001
- 2001-09-24 US US09/962,009 patent/US6683066B2/en not_active Expired - Fee Related
-
2002
- 2002-09-11 AU AU2002335736A patent/AU2002335736A1/en not_active Abandoned
- 2002-09-11 WO PCT/US2002/028918 patent/WO2003026565A2/en active Search and Examination
-
2003
- 2003-11-07 US US10/703,320 patent/US20040142905A1/en not_active Abandoned
- 2003-11-07 US US10/703,830 patent/US20040142906A1/en not_active Abandoned
- 2003-12-23 US US10/744,114 patent/US20040138125A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4830849A (en) * | 1980-04-14 | 1989-05-16 | Thomas Jefferson University | Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4780456A (en) * | 1984-10-10 | 1988-10-25 | Crinos Industria Farmacobiologica S.P.A. | Pharmaceutical or dietetic composition having a high antiarteriosclerotic activity |
JPH02102290A (en) * | 1988-10-07 | 1990-04-13 | Nippon Oil & Fats Co Ltd | Solubilized tocopherol |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 199021, Derwent World Patents Index; AN 1990-160455, XP002964689 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003026565A2 (en) | 2003-04-03 |
US20040138125A1 (en) | 2004-07-15 |
US20040142906A1 (en) | 2004-07-22 |
AU2002335736A1 (en) | 2003-04-07 |
US6683066B2 (en) | 2004-01-27 |
US20030059476A1 (en) | 2003-03-27 |
US20040142905A1 (en) | 2004-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003026565A3 (en) | Composition and treatment method for brain and spinal cord injuries | |
WO2004096216A3 (en) | Use of a topical medicament comprising riluzole | |
WO2012106444A3 (en) | Methods, devices and systems for treating insomnia by inducing frontal cerebral hypothermia | |
WO2005051329A3 (en) | Systems and methods for altering vestibular biology | |
WO2002036829A3 (en) | Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries | |
BG108461A (en) | Agent containing fat (oil), which contains oniion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue | |
WO2008052145A3 (en) | Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution | |
PT868186E (en) | USE OF CERTAIN ISOKINOLINOSULFONYL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA AND ETC ISCHEMIA | |
WO2002064069A3 (en) | Heat/cold treatment and devices used in pain treatment especially of acute tension headache and migraine | |
WO2006071548A3 (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases | |
WO2005030036A3 (en) | System and method for correction of intracerebral chemical imbalances | |
WO2000035475A3 (en) | Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia | |
EA200300560A1 (en) | IMPROVED TREATMENT METHOD | |
HK1020867A1 (en) | The topical use of kappa opioid agonists to treat ocular pain k | |
WO2004073607A3 (en) | Use of steroids to treat ocular disorders | |
WO2003049654A8 (en) | Protection of neurological tissue by direct cns perfusion cooling | |
WO2000009098A3 (en) | Method for treating ocular neovascular diseases | |
WO2004105689A3 (en) | Topical composition for the treatment of skin disorders and methods of using the same | |
WO2003092701A3 (en) | Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders | |
MXPA03001160A (en) | Method of treating neurodegenerative disorders of the retina and optic nerve head. | |
EP1297849A4 (en) | Remedial agent for optic nerve disease and the like | |
EP1420791A4 (en) | Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma | |
WO2018011756A1 (en) | Inflatable headgear | |
BRPI0414956A (en) | compositions of a selective cyclooxygenase-2 inhibitor administered under hypothermic conditions for the treatment of ischemia-mediated central nervous system disorders or lesions | |
TW200501958A (en) | A therapeutic agent for treating a behavioral disorder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |